Effects of Physiological Factors on the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in an Emulsion in Rats
スポンサーリンク
概要
- 論文の詳細を見る
The main absorption site of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate (AL-294) in rats was the upper portion of the small intestine. Both AL-294 and AL-294 acid (2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionic acid), a hydrolyzed form of AL-294,were absorbed in a smaller quantity under the bile fistula condition (pancretic juice and bile were excluded). Compared with the absorption of AL-294 as an emulsion under the sham operation condition, the sbsorption of AL-294 as the emulsion decreased under the condition where only pancreatic juice was excluded. The bioavailability under this condition was very similar to that under the bile fistula condition, whereas the absorption of AL-294 acid did not decrease when the pancreatic juice was excluded. From these results, the absorption mechanism of AL-294 is considered as follows : AL-294 was hydrolyzed to AL-294 acid by lipase in pancreatic juice, then AL-294 acid was solubilized with bile salts to form mixed micelles in the intestinal lumen. AL-294 acid from this form was easily absorbed into the systemic circulation. Absorption of AL-294 increased when the particle size of the emulsion was smaller. The reason was assumed to be that the smaller particle size offered the greater oil-water interface for lipase activity against AL-294.
- 社団法人日本薬学会の論文
- 1990-10-25
著者
-
島本 次雄
Pharmaceutics Research Laboratories Research And Development Division Takeda Chemical Industries Ltd
-
小川 泰亮
武田薬品工業株式会社 DDS研究所
-
戸口 始
Dds Research Laboratories Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
戸口 始
Pharmaceutical Development Laboratories Takeda Chemical Industries Ltd.
-
小川 泰亮
Pharmaceutics Research Laboratories, Research and Development Division, Takeda Chemical Industries,
-
伊賀 勝美
Pharmaceutics Research Laboratories, Research and Development Division, Takeda Chemical Industries,
-
伊賀 勝美
Pharmaceutics Research Laboratories Research And Development Division Takeda Chemical Industries Ltd
関連論文
- 徐放性マイクロカプセル製剤からの薬物放出性解析
- LHRH アゴニスト注射用マイクロカプセル徐放剤からの薬物放出in vitro評価系
- Quantitative Analysis of Hemolytic Action of Lysophosphatidylcholines in Vitro : Effect of Acyl Chain Structure
- 乳糖粉砕物の結晶水の挙動に関する研究
- Influence of Tablet Dimensions on the Disintegration Time
- Gastro-Intestinal Absorption of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate from Different Dosage Forms in Rats and Dogs
- A New Technique to Efficiently Entrap Leuprolide Acetate into Microcapsules of Polylactic Acid or Copoly(Lactic/Glycolic) Acid
- Stability of Packaged Solid Dosage Forms. VI. Shelf-life Prediction of Packaged Prednisolone Tablets in Relation to Dissolution Properties
- Stability of Packaged Solid Dosage Forms. V. Prediction of the Effect of Aging on the Disintegration of Packaged Tablets influenced by Moisture and Heat
- Stability of Packaged Solid Dosage Forms. III. Kinetic Studies by Differential Analysis on the Deterioration of Sugar-coated Tablets under the Influence of Moisture and Heat
- Stability of Packaged Solid Dosage Forms. II. Shelf-life Prediction for Packaged Sugar-coated Tablets Liable to Moisture and Heat Damage
- Stability of Packaged Solid Dosage Forms. I. Shelf-life Prediction for Packaged Tablets Liable to Moisture Damage
- Enhancement of the Anti-tumor Activity of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with an F (ab')_2 Fragment of Murine Monoclonal Antibody against rIL-2
- Pharmacokinetic Alteration in Rats of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with a Monoclonal Antibody against rIL-2
- 酢酸リュープロレリン徐放性注射剤
- Effects of Physiological Factors on the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in an Emulsion in Rats
- Effects of the Physicochemical Properties of the Emulsion Formulation of the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in Rats
- ポリ乳酸/グリコール酸を用いた甲状腺刺激ホルモン放出ホルモン徐放性マイクロスフェア
- In Vivo Release Profiles of Leuprolide Acetate from Microcapsules Prepared with Polylactic Acids or Copoly(Lactic/Glycolic) Acids and in Vivo Degradation of These Polymers
- Controlled-Release of Leuprolide Acetate from Polylactic Acid or Copoly(Lactic/Glycolic) Acid Microcapsules : Influence of Molecular Weight and Copolymer Ratio of Polymer
- Interaction of Methyl p-Hydroxybenzoate with Polyoxyethylene Dodecyl Ethers
- Ultrafiltration Method for Measuring Free Preservatives in Aqueous Phase of Oil-in-Water Emulsions
- ホルモン依存性疾患に有用な治療剤:リュ-プリン 長期徐放マイクロカプセルの設計
- 消化管粘膜付着性細粒剤の有効性評価におけるヒトと実験動物との比較
- 黄体形成ホルモン放出ホルモンアゴニストのDDS
- 第1回DDS研究会
- 安定性研究のための人工気象室
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の水溶液中でのマルトシル-β-シクロデキストリンによる安定化
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の安定性およびその分解機構
- A Model for the Evaluation and Prediction of Preservative Activity in Oil-in-Water Emulsions
- Effect of Polyols on the Interaction of p-Hydroxybenzoic Acid Esters with Polyoxyethylene Dodecyl Ether
- Interaction of p-Hydroxybenzoic Acid Esters with Polyethylene Glycol
- Interaction of Propyl p-Hydroxybenzoate with Polyoxyethylene Dodecyl Ethers
- Flocculation and Deflocculation of Veegum Suspensions by Polyoxyethylene Hydrogenated Castor Oil
- Theoretical Consideration on Dosage Variation